Article Per Year (5 Year)
p-Index From 2020 - 2025
0.61
P-Index
This Author published in this journals
All Journal Global Medical and Health Communication Sari Pediatri
Anggia Farrah Rizqiamuti, Anggia Farrah
Unknown Affiliation
Dentistry Health Professions Immunology & microbiology Nursing Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Autism Spectrum Disorder: a Two-center Evaluation of Pharmacological Intervention and Behavioral Therapies on Core Symptoms Solek, Purboyo; Gamayani, Uni; Rusmil, Kusnandi; Afriandi, Irvan; Prasetya, Taufan; Rizqiamuti, Anggia Farrah; Nurfitri, Eka; Burhan, Burhan; Sahril, Indra; Gunawan, Kevin
Global Medical & Health Communication (GMHC) Vol 12, No 3 (2024)
Publisher : Universitas Islam Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29313/gmhc.v12i3.14460

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by chronic deficits in social communication and interaction, with sensory processing abnormalities affecting over 90% of individuals across different sensory areas. This study investigated the combined effects of aripiprazole and behavioral therapy (BT) on core symptoms of ASD in children aged 6–10. Utilizing the considerable neuroplasticity still present at this age, we hypothesized that this combined approach might yield superior outcomes compared to BT alone. The 12-week randomized, double-blind, placebo-controlled trial was conducted from February 2023 to January 2024 at two sites of Child Development Centers in Bandung city, involving 51 participants (22 intervention, 29 placebo). The intervention group received aripiprazole and BT, while the placebo group received saccharum lactis and BT. Both groups underwent BT comprising applied behavioral analysis (ABA) and discrete trial training (DTT). The Childhood Autism Rating Scale (CARS) assessed treatment effects. The independent 2-sample t-tests and Mann-Whitney tests showed no significant differences in overall CARS scores between groups. However, the analysis revealed significant improvements in three subcategories: VII (visual response, p=0.021), IX (taste-smell-touch response, p=0.035), and X (fear or nervousness, p=0.043). These findings suggest that the combined approach may enhance sensory processing and emotional regulation in children with ASD. The study highlights the potential benefits of a multimodal approach to ASD treatment, combining targeted pharmacological intervention with behavioral therapies. However, limitations such as study duration and sample size warrant further research to optimize treatment strategies for individuals across the autism spectrum.
Profil Serum Serotonin dan Brain-Derived Neurotrophic Factor sebagai Indikator Kompleksitas Gejala Anak Autisme Usia 6-10 Tahun Solek, Purboyo; Gamayani, Uni; Rusmil, Kusnandi; Afriandi, Irvan; Prasetya, Taufan; Rizqiamuti, Anggia Farrah; Nurfitri, Eka; -, Burhan; Sahril, Indra; Gunawan, Kevin
Sari Pediatri Vol 27, No 2 (2025)
Publisher : Badan Penerbit Ikatan Dokter Anak Indonesia (BP-IDAI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14238/sp27.2.2025.96-101

Abstract

Latar belakang. Gangguan spektrum autisme (GSA) adalah gangguan neurodevelopmental kompleks yang melibatkan faktor neurobiologis seperti serotonin dan brain-derived neurotrophic factor (BDNF).Tujuan. Penelitian bertujuan untuk mengevaluasi kadar serotonin dan BDNF serum pada anak dengan autisme serta menilai potensinya sebagai biomarker diagnostik.Metode. Penelitian potong lintang melibatkan 51 anak autisme usia 6-10 tahun di Melinda dan Indigrow Child Development Center. Kadar serum serotonin dan BDNF dianalisis dengan metode ELISA dan dinilai berdasarkan tingkat kompleksitas gejala menggunakan Childhood Autism Rating Scale (CARS). Uji T-test independent digunakan untuk menganalisis perbedaan kedua biomarker berdasarkan tingkat kompleksitas gejala. Kadar serotonin dan BDNF dianalisis lebih lanjut menggunakan ROC.Hasil. Rerata kadar serotonin adalah 339,86 ng/ml, dengan perbedaan signifikan antara autisme ringan-sedang (398,82 ng/ml) dan berat (325,48 ng/ml) (p<0,05). Rerata kadar BDNF adalah 41,77 ng/ml, cenderung lebih tinggi pada autisme berat (42,92 ng/ml) dibandingkan autisme ringan-sedang (37,05 ng/ml), namun tidak signifikan (p>0,05). Analisis ROC menunjukkan nilai diagnostik suboptimal untuk kedua biomarker. Kesimpulan. Meskipun terdapat perbedaan kadar serotonin dan BDNF serum berdasarkan tingkat kompleksitas gejala anak autisme, namun penggunaannya sebagai biomarker diagnostik masih terbatas dan memerlukan penelitian lebih lanjut.
Autism Spectrum Disorder: a Two-center Evaluation of Pharmacological Intervention and Behavioral Therapies on Core Symptoms Solek, Purboyo; Gamayani, Uni; Rusmil, Kusnandi; Afriandi, Irvan; Prasetya, Taufan; Rizqiamuti, Anggia Farrah; Nurfitri, Eka; Burhan, Burhan; Sahril, Indra; Gunawan, Kevin
Global Medical & Health Communication (GMHC) Vol 12, No 3 (2024)
Publisher : Universitas Islam Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by chronic deficits in social communication and interaction, with sensory processing abnormalities affecting over 90% of individuals across different sensory areas. This study investigated the combined effects of aripiprazole and behavioral therapy (BT) on core symptoms of ASD in children aged 6–10. Utilizing the considerable neuroplasticity still present at this age, we hypothesized that this combined approach might yield superior outcomes compared to BT alone. The 12-week randomized, double-blind, placebo-controlled trial was conducted from February 2023 to January 2024 at two sites of Child Development Centers in Bandung city, involving 51 participants (22 intervention, 29 placebo). The intervention group received aripiprazole and BT, while the placebo group received saccharum lactis and BT. Both groups underwent BT comprising applied behavioral analysis (ABA) and discrete trial training (DTT). The Childhood Autism Rating Scale (CARS) assessed treatment effects. The independent 2-sample t-tests and Mann-Whitney tests showed no significant differences in overall CARS scores between groups. However, the analysis revealed significant improvements in three subcategories: VII (visual response, p=0.021), IX (taste-smell-touch response, p=0.035), and X (fear or nervousness, p=0.043). These findings suggest that the combined approach may enhance sensory processing and emotional regulation in children with ASD. The study highlights the potential benefits of a multimodal approach to ASD treatment, combining targeted pharmacological intervention with behavioral therapies. However, limitations such as study duration and sample size warrant further research to optimize treatment strategies for individuals across the autism spectrum. DOI: https://doi.org/10.29313/gmhc.v12i3.14460
Co-Authors -, Burhan Burhan Burhan, Burhan Eka Nurfitri, Eka Irvan Afriandi Kevin Gunawan Kusnandi Rusmil Prasetya, Taufan Sahril, Indra Solek, Purboyo Uni Gamayani, Uni